CNS metastasis: an old problem in a new guise

Area of Science:

• Oncology
• Neurology
• Cancer Metastasis

Background:

• Central nervous system (CNS) metastases affect 10-30% of solid tumor patients, with increasing incidence due to aging populations and improved systemic disease control.
• Common primary sites include lung, breast, melanoma, kidney, and colorectal cancers.
• CNS metastases significantly increase morbidity and mortality, impacting survival, neurocognition, speech, coordination, behavior, and quality of life.

Purpose of the Study:

• To review the current understanding and challenges of central nervous system (CNS) metastases in solid tumors.
• To highlight key areas including HER-2-positive breast cancer, model systems, blood-brain barrier physiology, and radiotherapy strategies.
• To identify critical areas for future research in the prevention and treatment of CNS metastases.

Main Methods:

• This review synthesizes information from existing literature and expert discussions.
• Focus areas include HER-2-positive breast cancer as a model, pathogenesis insights, blood-brain barrier (BBB) physiology, and radiotherapy's role.
• Discussion encompasses strategies to improve therapeutic index and address sanctuary sites.

Main Results:

• Brain metastases are an increasing clinical problem, particularly in solid tumors.
• Effective management requires understanding unique CNS challenges, including the blood-brain barrier.
• Radiotherapy plays an evolving role, with ongoing efforts to enhance its therapeutic index.

Conclusions:

• CNS metastases represent a significant and growing challenge in oncology, demanding novel therapeutic strategies.
• Future research must focus on site-specific metastasis, drug delivery to sanctuary sites, and long-term neurocognitive and quality-of-life effects.
• A multidisciplinary approach is essential to improve outcomes for patients with CNS metastases.